FDA Approves Aduhelm for Alzheimer Disease
Agency says it has granted approval on the condition that drug maker Biogen conduct a new clinical trial
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Agency says it has granted approval on the condition that drug maker Biogen conduct a new clinical trial
Only registered members have full access to PracticeUpdate content.